Abeona Therapeutics (ABEO) EBT (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly EBT of -$17.1 million for Q1 2026, down 41.93% year-over-year from -$29.4 million in Q1 2025, and up 17.42% quarter-over-quarter from -$20.7 million in Q4 2025.
Abeona Therapeutics (ABEO) EBT (2011 - 2026) Analysis & Trends
Abeona Therapeutics' EBT history runs 16 years deep, the most recent figure standing at -$17.1 million for Q1 2026.
- In Q1 2026, EBT fell 41.93% year-over-year to -$17.1 million; the TTM figure through Mar 2026 stood at $66.2 million (up 249.91% YoY), while the FY2025 annual figure was $71.3 million, up 211.84% from the prior year.
- EBT for Q1 2026 stood at -$17.1 million, up from -$20.7 million in the prior quarter.
- The five-year high for EBT was $124.3 million in Q2 2025, with the low at -$32.1 million in Q1 2022.
- The 5-year median for EBT is -$13.3 million (2023), against an average of -$7.5 million.
- The sharpest annual moves came in 2024 and 2025: EBT tumbled 138.26% in 2024, then soared 1578.98% in 2025.
- Abeona Therapeutics' EBT stood at -$13.1 million in 2022, then dropped by 1.56% to -$13.3 million in 2023, then soared by 30.22% to -$9.3 million in 2024, then tumbled by 122.48% to -$20.7 million in 2025, then grew by 17.42% to -$17.1 million in 2026.
- Business Quant data shows ABEO's EBT at -$17.1 million in Q1 2026, -$20.7 million in Q4 2025, and -$20.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | -20.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.19 Mn |
| Mar 31, 2026 | -17.07 Mn |
| Dec 31, 2025 | -20.68 Mn |
| Sep 30, 2025 | -20.36 Mn |
| Jun 30, 2025 | 124.35 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -9.29 Mn |
| Sep 30, 2024 | -30.27 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | -16.33 Mn |
| Dec 31, 2023 | -13.32 Mn |
| Sep 30, 2023 | -12.70 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | -20.99 Mn |
| Dec 31, 2022 | -13.11 Mn |
| Sep 30, 2022 | -11.01 Mn |
| Jun 30, 2022 | -18.66 Mn |
| Mar 31, 2022 | -32.10 Mn |
| Dec 31, 2021 | -43.45 Mn |
| Sep 30, 2021 | -15.79 Mn |